The normal circadian pattern of blood pressure: Implications for treatment

International Journal of Clinical Practice, Supplement

Volumn , Issue 145, 2004, Pages 3-8

  Redon, Josep ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Blood pressure; Cardiovascular disease; Cerebrovascular disease; Chronotherapy; Circadian rhythm

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; TELMISARTAN;

ACUTE HEART INFARCTION; ANGINA PECTORIS; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHRONOTHERAPY; CIRCADIAN RHYTHM; DRUG EFFECT; DRUG HALF LIFE; DRUG MECHANISM; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERTENSION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK BENEFIT ANALYSIS; STROKE;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; CHRONOTHERAPY; CIRCADIAN RHYTHM; HUMANS; HYPERTENSION;

EID: 10344233137     PISSN: 1368504X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Elliott WJ. Timing treatment to the rhythm of disease. A short course in chronotherapeutics. Postgrad Med 2001; 110: 119-22,125-6,129.
2. Anwar YA, White WB. Chronotherapeutics for cardiovascular disease. Drugs 1998; 55: 631-43.
3. Millar-Craig MW, Bishop CN, Raftery EB. Circadian variation of blood-pressure. Lancet 1978; i: 795-7.
4. Mancia G, Parati G. Ambulatory blood pressure monitoring and organ damage. Hypertension 2000; 36: 894-900.
5. Smolensky MH, D'Alonzo GE. Medical chronobiology: concepts and applications. Am Rev Respir Dis 1993; 147 (2 Part 2): S2-S19.
6. Sundberg S, Kohvakka A, Gordin A. Rapid reversal of circadian blood pressure rhythm in shift workers. J Hypertens 1988; 6: 393-6.
7. Kitamura T, Onishi K, Dohi K, et al. Circadian rhythm of blood pressure is transformed from a dipper to a non-dipper pattern in shift workers with hypertension. J Hum Hypertens 2002; 16: 193-7.
8. Murata K, Yano E, Shinozaki T. Impact of shift work on cardiovascular functions in a 10-year follow-up study. Scand J Work Environ Health 1999; 25: 272-7.
9. Tenkanen L, Sjoblom T, Kalimo R, et al. Shift work, occupation and coronary heart disease over 6 years of follow-up in the Helsinki Heart Study. Scand J Work Environ Health 1997; 23: 257-65.
10. Mancia G, Sega R, Milesi C, et al. Blood-pressure control in the hypertensive population. Lancet 1997; 349: 454-7.
11. Harshfield GA, Hwang C, Grim CE. Circadian variation of blood pressure in blacks: influence of age, gender and activity. J Hum Hypertens 1990; 4: 43-7.
12. Staessen JA, Bieniaszewski L, O'Brien E, et al. Nocturnal blood pressure fall on ambulatory monitoring in a large international database. Hypertension 1997; 29: 30-9.
13. White WB. Ambulatory blood pressure monitoring dippers compared with non-dippers. Blood Press Monit 2000; 5 (Suppl. 1): S17-S23.
14. Lurbe E, Redon J, Pascual JM, et al. The spectrum of circadian blood pressure changes in type 1 diabetic patients. J Hypertens 2001; 19: 1421-8.
15. Redon J. Ambulatory blood pressure and the kidney. Blood Press Monit 1998; 3: 157-61.
16. O'Brien E, Sheridan J, O'Malley K. Dippers and non-dippers. Lancet 1988; ii: 397.
17. Pickering TG. The clinical significance of diurnal blood pressure variations. Dippers and nondippers. Circulation 1990; 81: 700-2.
18. Verdecchia P, Porcellati C, Schillaci G, et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994; 24: 793-801.
19. Verdecchia P. Prognostic value of ambulatory blood pressure: current evidence and clinical implications. Hypertension 2000; 35: 844-51.
20. Lurbe E, Redon J, Kesani A, et al. Increase in nocturnal blood pressure and microalbuminuria in type 1 diabetes. N Engl J Med 2002; 347: 797-805.
21. Omboni S, Parati G, Palatini P, et al. Reproducibility and clinical value of nocturnal hypotension: prospective evidence from the SAMPLE study. Study on Ambulatory Monitoring of Pressure and Lisinopril Evaluation. J Hypertens 1998; 16: 733-8.
22. Mulcahy D, Keegan J, Cunningham D, et al. Circadian variation of total ischaemic burden and its alteration with anti-anginal agents. Lancet 1988; ii: 755-9.
23. Willich SN, Levy D, Rocco MB, et al. Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population. Am J Cardiol 1987; 60: 801-6.
24. Muller JE, Stone PH, Turi ZG, et al. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 1985; 313: 1315-22.
25. Taylor CR, Hodge EM, White DA. The Amlodipine Angina Study Group. Circadian rhythm of angina: similarity to circadian rhythms of myocardial infarction, ischemic ST segment depression, and sudden cardiac death. Am Heart J 1989; 118: 1098-9.
26. Siegel D, Black DM, Seeley DG, et al. Circadian variation in ventricular arrhythmias in hypertensive men. Am J Cardiol 1992; 69: 344-7.
27. Raeder E, Hohnloser SH, Graboys TB, et al. Spontaneous variability and circadian distribution of ectopic activity in patients with malignant ventricular arrhythmia. J Am Coll Cardiol 1988; 12: 656-61.
28. Mulcahy D. Circadian variation in cardiovascular events. Blood Press Monit 1998; 3: 29-34.
29. Marler JR, Price TR, Clark GL, et al. Morning increase in onset of ischemic stroke. Stroke 1989; 20: 473-6.
30. Cohen MC. Meta-analysis of the morning excess of acute myocardial infarction and sudden cardiac death. Am J Cardiol 1997; 79: 1512-6.
31. Elliott WJ. Circadian variation in the timing of stroke onset - a meta-analysis. Stroke 1998; 29: 992-6.
32. Arntz H-R, Willich SN, Schreiber C, et al. Diurnal, weekly and seasonal variation of sudden death. Population-based analysis of 24 061 consecutive cases. Eur Heart J 2000; 21: 315-20.
33. Tofler GH, Brezinski D, Schafer AI, et al. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med 1987; 316: 1514-8.
34. Rocco MB, Barry J, Campbell S, et al. Circadian variation of transient myocardial ischemia in patients with coronary artery disease. Circulation 1987; 75: 395-400.
35. Marchant B, Stevenson R, Vaishnav S, et al. Influence of the autonomic nervous system on circadian patterns of myocardial ischaemia: comparison of stable angina with the early postinfarction period. Br Heart J 1994; 71: 329-33.
36. Hausmann D, Nikutta P, Trappe HJ, et al. Circadian distribution of the characteristics of ischemic episodes in patients with stable coronary artery disease. Am J Cardiol 1990; 66: 668-72.
37. Hausmann D, Lichtlen PR, Nikutta P, et al. Circadian variation of myocardial ischemia in patients with stable coronary artery disease. Chronobiol Int 1991; 8: 385-98.
38. Egstrup K. Transient myocardial ischaemia during ambulatory monitoring out of hospital in patients with chronic stable angina pectoris. Acta Med Scand 1988; 224: 311-8.
39. Wood MA, Simpson PM, London WB, et al. Circadian pattern of ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators. J Am Coll Cardiol 1995; 25: 901-7.
40. Twidale N, Taylor S, Heddle WF, et al. Morning increase in the time of onset of sustained ventricular tachycardia. Am J Cardiol 1989; 64: 1204-6.
41. Lampert R, Rosenfeld L, Batsford W, et al. Circadian variation of sustained ventricular tachycardia in patients with coronary artery disease and implantable cardioverter-defibrillators. Circulation 1994; 90: 241-7.
42. Behrens S, Ehlers C, Bruggemann T, et al. Modification of the circadian pattern of ventricular tachyarrhythmias by beta-blocker therapy. Clin Cardiol 1997; 20: 253-7.
43. Gallerani M, Manfredini R, Ricci L, et al. Chronobiological aspects of acute cerebrovascular diseases. Acta Neurol Scand 1993; 87: 482-7.
44. Kelly-Hayes M, Wolf PA, Kase CS, et al. Temporal patterns of stroke onset. Stroke 1995; 26: 1343-7.
45. Willich SN, Linderer T, Wegscheider K, et al. Increased morning incidence of myocardial infarction in the ISAM Study: absence with prior beta-adrenergic blockade. Circulation 1989; 80: 853-8.
46. Pickering TG, James GD. Determinants and consequences of the diurnal rhythm of blood pressure. Am J Hypertens 1993; 6 (6 Part 2): 166S-169S.
47. Gordon RD, Wolfe LK, Island DP, et al. A diurnal rhythm in plasma renin activity in man. J Clin Invest 1966; 45: 1587-92.
48. Weitzman ED, Fukushima D, Nogeire C, et al. Twenty-four hour pattern of the episodic secretion of cortisol in normal subjects. J Clin Endocrinol Metab 1971; 33: 14-22.
49. Turton MB, Deegan T. Circadian variations of plasma catecholamine, cortisol and immunoreactive insulin concentrations in supine subjects. Clin Chim Acta 1974; 55: 389-97.
50. Brezinski DA, Tofler GH, Muller JE, et al. Morning increase in platelet aggregability. Association with assumption of the upright posture. Circulation 1988; 78: 35-40.
51. Cooke-Ariel H. Circadian variations in cardiovascular function and their relation to the occurrence and timing of cardiac events. Am J Health-Syst Pharm 1998; 55: S5-S11.
52. Muller JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 1989; 79: 733-43.
53. White WB. Heart rate and the rate-pressure product as determinants of cardiovascular risk in patients with hypertension. Am J Hypertens 1999; 12 (2 Part 2): 50S-55S.
54. Rocco MB, Nabel EG, Selwyn AP. Circadian rhythms and coronary artery disease. Am J Cardiol 1987; 59: 13C-17C.
55. Parati G, Pomidossi G, Albini F, et al. Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens 1987; 5: 93-8.
56. Eisen SA, Miller DK, Woodward RS, et al. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 1990; 150: 1881-4.
57. Burnier M, Maillard M. The comparative pharmacology of angiotensin II receptor antagonists. Blood Press 2001; 10 (Suppl. 1): 6-11.
58. Schwocho LR, Masonson HN. Pharmacokinetics of CS-866, a new angiotensin II receptor blocker, in healthy subjects. J Clin Pharmacol 2001; 41: 515-27.
59. Wienen W, Entzeroth M, van Meel JCA, et al. A review on telmisartan: a novel, long-acting angiotensin II-receptor antagonist. Cardiovasc Drug Rev 2000; 18: 127-56.
60. White WB, Lacourcière Y, Davidai G. Effects of the angiotensin II receptor blockers telmisartan versus valsartan in the circadian variation of blood pressure: impact of the early morning period. Am J Hypertens 2004; 17: 347-53.
61. Neutel J, Smith DH. Evaluation of angiotensin II receptor blockers for 24-hour blood pressure control: meta-analysis of a clinical database. J Clin Hypertens 2003; 5: 58-63.
62. Lacourcière Y, Krzesinski J-M, White WB, et al. Sustained antihypertensive activity of telmisartan compared with valsartan. Blood Press Monit 2004; 9: 203-10.